N/A
N=138
Adaptive Implementation Intervention for VA Suicide Risk Identification Strategy
Suicide
Bottom Line
View on ClinicalTrials.gov: NCT04243330 ↗Enrolled (actual)
138
Serious AEs
—
Results posted
May 2025
Primary outcome: Primary: Change in Columbia Suicide Severity Rating Scale Screener (C-SSRS) Uptake- Phase 1 — 13.0; 11.9 change in percent adherence — p=0.18
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Audit and Feedback (Behavioral); External Facilitation (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Dec 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Columbia Suicide Severity Rating Scale Screener (C-SSRS) Uptake- Phase 1 |
13.0; 11.9 | 0.18 |
| PRIMARY Change in Comprehensive Suicide Risk Evaluation (CSRE) Uptake- Phase 1 |
11.0; 7.45 | .06 |
| SECONDARY Change in Columbia Suicide Severity Rating Scale Screener (C-SSRS) Uptake- Phase 2a |
13.3; 11.7 | 0.60 |
| SECONDARY Change in Comprehensive Suicide Risk Evaluation (CSRE) Uptake-Phase 2a |
6.2; 10.2 | 0.36 |
| SECONDARY Change in Columbia Suicide Severity Rating Scale Screener (C-SSRS) Uptake- Phase 2b |
18.9; 23.4 | .02 sig |
| SECONDARY Change in Comprehensive Suicide Risk Evaluation (CSRE) Uptake-Phase 2b |
13.0; 13.6 | 0.82 |
Summary
The overall objective of this national quality improvement project is to develop an adaptive implementation strategy to improve the implementation of suicide risk screening and evaluation in Veterans Health Administration ambulatory care settings (i.e., VA Risk ID).
Eligibility Criteria
Inclusion Criteria
- Intervention occurs at the site/facility level. Up to 140 VHA facilities across the country will participate in the project. Sites will be allocated to various interventions based on performance (i.e., pre-determined benchmarks for adequate implementation).
Exclusion Criteria
- This is a national quality improvement project. Sites that are randomized to different intervention arms based on performance may refuse to participate in the implementation interventions.
Data sourced from ClinicalTrials.gov (NCT04243330). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.